參考文獻(xiàn)/References:
[1] Metzger B E, Coustan D R, Committee O.Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus[J].Diabetes care,1998, 21(2):161-167.
[2] Golab B P, Santos S, Voerman E, et al.Influence of maternal obesity on the association between common pregnancy complications and risk of childhood obesity: an individual participant data meta-analysis[J].The Lancet Child & Adolescent Health 2018, 2(11):812-821.
[3] Farahvar S, Walfisch A, Sheiner E.Gestational diabetes risk factors and long-term consequences for both mother and offspring: a literature review[J].Expert review of endocrinology & metabolism,2019, 14(1):63-74.
[4] Hod M, Kapur A, Sacks D A, et al.The international federation of gynecology and obstetrics(FIGO)initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care[J].Int J Gynaecol Obstet,2015, 131(3):173-211.
[5] Wei Y M, Yang H X, Zhu W W, et al.International association of diabetes and pregnancy study group criteria is suitable for gestational diabetes mellitus diagnosis: further evidence from China[J].Chin Med J(Engl), 2014,127(20):3553-3556.
[6] 楊慧霞.妊娠合并糖尿病——臨床實(shí)踐指南(2版)[M].人民衛(wèi)生出版社,2013.
[7] Luster A D, Unkeless J C,Ravetch J V, et al.Gamma interferon transcriptionally regulates all early-response gene containing homology to platelet proteins[J].Nature 1985, 315(6021): 672-676.
[8] Ejrnaes M,Videbaek N,Christen U,et al.Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10(CXC chemokine ligand 10)production but not cytokine expression, cytolytic activity, or homing characteristics [J].Immunol,2005, 174(5): 2746-2755.
[9] Krebs D L, Hilton D J.SOCS: physiological suppressors of cytokine signaling[J].J Cell Sci,2000,113(16):2813-2819.
[10] 許燕萍,梁黎.SOCS3在肥胖及糖尿病發(fā)病中的作用[J].國(guó)際兒科學(xué)雜志, 2007, 34(4): 293-295.
[11] 金芬芬, 宋若會(huì), 屠彥紅.NLRP3炎性小體研究進(jìn)展[J].中醫(yī)藥臨床雜志,2018,30(3): 564-567.
[12] Esser N, Lhomme L, De R A, et al.Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue[J].Diabetologia, 2013, 56(11):2487-2497.
[13] Vandanmagsar B, Youm Y H, Ravussin A, et al.The NLRP3 inflammasome instigates obesity-induced infla mmation and insulin resistance [J].Nature Medicine, 2011, 17(2):179-188.
[14] 廉凱,杜靖遠(yuǎn).白細(xì)胞介素1刺激破骨細(xì)胞骨性吸收作用的實(shí)驗(yàn)研究[J].中國(guó)現(xiàn)代醫(yī)學(xué)雜志, 2001,11(100):6-8.
[15] Marculescu R, Endler G, Schillinger M, et al.Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes[J].Diabetes, 2002, 51(12):3582-3585.
[16] Rothlein R.Dustin M L, Marlin S D, et al. A human intercellular adhesion molecule-1(ICAM-1)distinct from LFA-1[J].Immunol, 1986, 137(4):1270-1274.
[17] Chen W, Royer WE Jr.Structural insights into interferon regulatory factor activation [J].Cell Signal, 2010, 22(6):883-887.
[18] Zhang L, Pagano J S.Interferon regulatory factor 7: a key cellular mediator of lmp-1 in ebv latency and transformation[J].Semin Cancer Biol,2001,11(6): 445-453.
[19] Subiabre M, Villalobos-Labra R, Silva L, et al.Role of insulin, adenosine, and adipokine receptors in the foetoplacental vascular dysfunction in gestational diabetes mellitus[J].Biochim Biophys Acta Mol Basis Dis, 2019, 17(18): 925-939.
[20] Plows J F, Stanley J L, Baker P N, et al.The pathophysiology of gestational diabetes mellitus[J].Int J Mol Sci, 2018, 19(11):1-21.
[21] Mukerji G, Feig D S.Pharmacological management of gestational diabetes mellitus [J].Drugs, 2017, 77(16):1723-1732.